|
TMEM87B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.798200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.665920E-02 |
| Normal-vs-Stage2 |
7.032400E-01 |
| Normal-vs-Stage3 |
2.577200E-01 |
| Normal-vs-Stage4 |
4.480200E-01 |
| Stage1-vs-Stage2 |
4.118500E-02 |
| Stage1-vs-Stage3 |
3.059400E-01 |
| Stage1-vs-Stage4 |
3.167200E-01 |
| Stage2-vs-Stage3 |
2.176600E-01 |
| Stage2-vs-Stage4 |
3.652600E-01 |
| Stage3-vs-Stage4 |
8.258200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.195500E-02 |
| Normal-vs-AfricanAmerican |
1.363440E-01 |
| Normal-vs-Asian |
3.258100E-02 |
| Caucasian-vs-AfricanAmerican |
7.724600E-01 |
| Caucasian-vs-Asian |
4.228000E-01 |
| AfricanAmerican-vs-Asian |
7.592000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.748000E-01 |
| Normal-vs-Female |
2.960500E-02 |
| Male-vs-Female |
1.316810E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.041500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.325600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.860000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.268800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.283600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.146240E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.348200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.803000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.836200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.947400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.393600E-01 |
| Classical-VS-Follicular |
2.41590000005232E-07 |
| Classical-VS-Other |
7.766300E-02 |
| Classical-VS-Normal |
1.281470E-03 |
| Tall-VS-Follicular |
4.859700E-03 |
| Tall-VS-Other |
9.016100E-02 |
| Tall-VS-Normal |
3.910200E-02 |
| Follicular-VS-Other |
9.686000E-01 |
| Follicular-VS-Normal |
1.055970E-01 |
| Other-VS-Normal |
3.761200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.755400E-01 |
| Normal-vs-N1 |
3.434000E-01 |
| N0-vs-N1 |
5.417600E-01 |
|
|
